Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.

Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats. J Hepatol. 2009 Nov; 51(5):865-73.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.